J1265
J1265 – Injection, dopamine hcl, 40 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 29 NDCs crosswalked per 40 MG $1.012/unit ASP+6%
📋 J1265 summary
J1265 is a HCPCS Level II J-code used to bill dopamine hcl, 40 mg, billed per 40 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J1265: Dopamine Hcl In, Dopamine Hydrochloride, Dopamine Hydrochloride And Dextrose
Code J1265
Billing unit 40 MG Payment limit $1.012/unit NDC-Crosswalk 29
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ1265
DescriptorInjection, dopamine hcl, 40 mg
Billing unit40 MG
Payment limit / unit$1.012
Est. ASP / unit$0.955 est.
Mapped NDCs29
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.012
Est. ASP / unit
$0.955 est.
Est. after 2% sequester
$0.992
HCPCS dosage
40 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, dopamine hcl, 40 mg
CoverageC — Carrier/MAC judgment
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date2006-01-01
Date added2006-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J1265 = 40 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J1265 WITH EST. MEDICARE PAY
29 NDCs map to J1265. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.012/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9252-25 | Dopamine Hydrochloride 40 mg/mL INJECTION | Hikma | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-925... | 40 mg/mL | 125 | $126.50 | — | ● Active | CMS + PDAC |
| 00143-9254-25 | Dopamine Hydrochloride 40 mg/mL INJECTION | Hikma | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-925... | 40 mg/mL | 250 | $253.00 | — | ● Active | CMS + PDAC |
| 00338-1005-02 | Dopamine Hydrochloride and Dextrose 80 mg/100mL INJECTION, SOLUTION | Baxter | 18 BAG in 1 CARTON (0338-1005-02) / 250 m... | 80 mg/100mL | 90 | $91.08 | — | ● Active | CMS + PDAC |
| 00338-1005-03 | Dopamine Hydrochloride and Dextrose 80 mg/100mL INJECTION, SOLUTION | Baxter | 12 BAG in 1 CARTON (0338-1005-03) / 500 m... | 80 mg/100mL | 120 | $121.44 | — | ● Active | CMS + PDAC |
| 00338-1007-02 | Dopamine Hydrochloride and Dextrose 160 mg/100mL INJECTION, SOLUTION | Baxter | 18 BAG in 1 CARTON (0338-1007-02) / 250 m... | 160 mg/100mL | 180 | $182.16 | — | ● Active | CMS + PDAC |
| 00338-1007-03 | Dopamine Hydrochloride and Dextrose 160 mg/100mL INJECTION, SOLUTION | Baxter | 12 BAG in 1 CARTON (0338-1007-03) / 500 m... | 160 mg/100mL | 240 | $242.88 | — | ● Active | CMS + PDAC |
| 00338-1009-02 | Dopamine Hydrochloride and Dextrose 320 mg/100mL INJECTION, SOLUTION | Baxter | 18 BAG in 1 CARTON (0338-1009-02) / 250 m... | 320 mg/100mL | 360 | $364.32 | — | ● Active | CMS + PDAC |
| 00404-9981-10 | Dopamine Hydrochloride 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | Henry | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9981-10... | 40 mg/mL | 10 | $10.12 | — | ● Active | CMS ASP |
| 00404-9982-05 | Dopamine Hydrochloride 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | Henry | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9982-05... | 40 mg/mL | 5 | $5.06 | — | ● Active | CMS ASP |
| 00409-0042-12 | Dopamine Hydrochloride in Dextrose 1.6 mg/mL INJECTION, SOLUTION | Hospira, | 12 POUCH in 1 CASE (0409-0042-12) / 1 BAG... | 1.6 mg/mL | 120 | $121.44 | — | ● Active | CMS ASP |
| 00409-1858-12 | Dopamine Hydrochloride in Dextrose 3.2 mg/mL INJECTION, SOLUTION | Hospira, | 12 POUCH in 1 CASE (0409-1858-12) / 1 BAG... | 3.2 mg/mL | 240 | $242.88 | — | ● Active | CMS ASP |
| 00409-5820-01 | DOPamine Hydrochloride 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | Hospira, | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-5820-... | 40 mg/mL | 125 | $126.50 | — | ● Active | CMS + PDAC |
| 00409-7809-22 | Dopamine | Pfizer | — | — | 120 | $121.44 | — | — | CMS + PDAC |
| 00409-7809-24 | Dopamine Hydrochloride in Dextrose 1.6 mg/mL INJECTION, SOLUTION | Hospira, | 12 BAG in 1 CARTON (0409-7809-24) / 500 m... | 1.6 mg/mL | 240 | $242.88 | — | ● Active | CMS + PDAC |
| 00409-7810-22 | Dopamine | Pfizer | — | — | 240 | $242.88 | — | — | CMS + PDAC |
| 00409-9104-20 | DOPamine Hydrochloride 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | Hospira, | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9104-... | 40 mg/mL | 250 | $253.00 | — | ● Active | CMS + PDAC |
| 51662-1220-01 | DOPAMINE HCI 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | HF | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1220-1... | 40 mg/mL | 10 | $10.12 | — | ● Active | CMS ASP |
| 51662-1220-03 | DOPAMINE HCI 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | HF | 25 POUCH in 1 CASE (51662-1220-3) / 1 VIA... | 40 mg/mL | 250 | $253.00 | — | ● Active | CMS ASP |
| 51662-1291-01 | DOPAMINE HCI 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | HF | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1291-1) | 40 mg/mL | 5 | $5.06 | — | ● Active | CMS ASP |
| 51662-1291-03 | DOPAMINE HCI 40 mg/mL INJECTION, SOLUTION, CONCENTRATE | HF | 25 POUCH in 1 CASE (51662-1291-3) / 1 VIA... | 40 mg/mL | 125 | $126.50 | — | ● Active | CMS ASP |
| 51662-1316-01 | DOPAMINE HYDROCHLORIDE 1.6 mg/mL INJECTION, SOLUTION | HF | 250 mL in 1 BAG (51662-1316-1) | 1.6 mg/mL | 10 | $10.12 | — | ● Active | CMS ASP |
| 51662-1316-03 | DOPAMINE HYDROCHLORIDE 1.6 mg/mL INJECTION, SOLUTION | HF | 12 POUCH in 1 CASE (51662-1316-3) / 1 BAG... | 1.6 mg/mL | 120 | $121.44 | — | ● Active | CMS ASP |
| 51662-1458-01 | DOPAMINE HCI IN 5% DEXTROSE 1.6 mg/mL INJECTION, SOLUTION | HF | 500 mL in 1 BAG (51662-1458-1) | 1.6 mg/mL | 20 | $20.24 | — | Obsolete | CMS ASP |
| 51662-1489-01 | DOPAMINE HYDROCHLORIDE 40 mg/mL INJECTION | HF | 5 mL in 1 VIAL, SINGLE-DOSE (51662-1489-1) | 40 mg/mL | 5 | $5.06 | — | ● Active | CMS ASP |
| 51662-1489-03 | DOPAMINE HYDROCHLORIDE 40 mg/mL INJECTION | HF | 25 POUCH in 1 CASE (51662-1489-3) / 1 VIA... | 40 mg/mL | 125 | $126.50 | — | ● Active | CMS ASP |
| 51662-1490-01 | DOPAMINE HYDROCHLORIDE 40 mg/mL INJECTION | HF | 10 mL in 1 VIAL, SINGLE-DOSE (51662-1490-1... | 40 mg/mL | 10 | $10.12 | — | ● Active | CMS ASP |
| 00143-9252-01 | DOPAMINE HCL (SDV,LATEX-FREE) 40 MG/1 ML | Unknown | — | — | 1 | $1.01 | — | — | PDAC |
| 00143-9254-01 | DOPAMINE HCL (LATEX-FREE) 40 MG/1 ML | Unknown | — | — | 1 | $1.01 | — | — | PDAC |
| 51927-2319-00 | DOPAMINE HCL | Unknown | — | — | 25 | $25.30 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$3.1K
Claims
74
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$42.05
Trend by period
Where J1265 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #728 of 824
#723
LEVOTHYROXINE SODIUM... J0650
$3.4K
#724
MESNA* J9209
$3.4K
#725
CYSTO-CONRAY II* Q9958
$3.3K
#726
ENGERIX-B PEDIATRIC-... 90744
$3.2K
#727
TESTOSTERONE ENANTHA... J3121
$3.1K
#728
DOPAMINE HCL IN 5% D... J1265
$3.1K
#729
HALDOL DECANOATE 100... J1631
$3.1K
#730
GEMCITABINE HCL(J919... J9196
$3K
#731
PAMIDRONATE DISODIUM J2430
$3K
#732
LEVOFLOXACIN-D5W J1956
$2.9K
#733
CLEOCIN PHOSPHATE* J0736
$2.8K
Total claims — #655 of 824
#650
PROCAINAMIDE HCL J2690
79
#651
VALPROATE SODIUM J3379
79
#652
KEPPRA* J1953
75
#653
VASOPRESSIN-0.9% NAC... J2601
75
#654
CYGNUS DUAL PER SQ C... Q4282
75
#655
DOPAMINE HCL IN 5% D... J1265
74
#656
THYMOGLOBULIN J7511
74
#657
NEBUPENT(J2516)* J2516
73
#658
WILATE J7183
73
#659
BIZENGRI J9382
73
#660
PRIMATRIX** Q4110
73
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $3.1K | — | 74 | — | $42.05 |
| 2025 (Q1-Q4) | $12.6K | 13 | 363 | $972.91 | $34.84 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$12.7K
Medicare paid
$9.7K
Submitted services
17,520
Denial rate
2.2%
Allowed / service
$0.74
Submitted charges
$83.4K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J1265
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
29 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J1265 billing FAQ
What is HCPCS code J1265?
J1265 is a HCPCS Level II J-code used to bill Injection, dopamine hcl, 40 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1265?
One unit of J1265 represents 40 MG. Report the number of units equal to the dose administered divided by 40 MG.
How many units of J1265 should I bill?
Divide the dose administered by the code's unit size (40 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1265?
The Medicare Part B payment limit is $1.012 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.992 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1265?
29 NDCs currently map to J1265 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1265 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.